HSBC Holdings PLC (HSBA)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 1,352.00 |
|---|---|
| 52-week range | 979.80 – 1,610.00 |
| Return, 1 month / 3 months | −10.7% / −11.0% |
| Return, 1 year / 3 years | +42.3% / +169.9% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 26.5% |
| Worst drawdown (1 year) | -16.0% |
| Average daily value traded | 33,443.57M GBX |
| Dividend yield | 4.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
HSBC Holdings is a banking and financial services group based in London. It serves personal customers, small businesses, large corporations and institutional clients through retail banking, commercial banking, wealth management and global banking and markets. Its network spans Asia, Europe, the Middle East, Africa and the Americas, with a particularly strong presence in Hong Kong and mainland China. The group offers current accounts, loans, mortgages, credit cards, payments, trade finance, investment services and treasury products to customers across its markets.
On this site HSBC Holdings PLC appears as a stock on the London Exchange (UK), code HSBA, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
HSBC Holdings PLC (HSBA) trades on the London Exchange in UK. It last closed at GBX 1,352.00 on 23 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 626 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 42.3% and over the last three months it fell 11.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.4% | ||
| From 52-week high | -15.4% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -11.0% | ||
| 6-month return | 2.1% | ||
| 12-month return, skipping the last month | 59.4% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.0% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 33,443.57M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 54 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.1% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −5.3% |
|---|---|
| 1 month | −10.7% |
| 3 months | −11.0% |
| 6 months | +2.1% |
| 1 year | +42.3% |
| 3 years | +169.9% |
| 5 years | +319.6% |
Signals
| 50-day / 200-day average | 1,488.34 / 1,371.64 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 30.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | GBP 0.0741 |
| 14 May 2026 | GBP 0.0745 |
| 12 Mar 2026 | GBP 0.3330 |
| 6 Nov 2025 | GBP 0.0751 |
| 14 Aug 2025 | GBP 0.0736 |
| 8 May 2025 | GBP 0.0737 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.